BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7670404)

  • 1. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
    Douay L; Giarratana MC; Labopin M; Bardinet D; Bouchet S; Gorin NC
    Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC; Gorin NC; Douay L
    Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
    Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
    Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L; Giarratana MC; Poloni A; Firat H; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC; Mormont C; Thomas F; Berthier R
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells.
    Rice A; Barbot C; Lacombe F; Dubosc-Marchenay N; Marit G; Hau F; Boiron JM; Reiffers J
    Stem Cells; 1993 Jul; 11(4):326-35. PubMed ID: 8401256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
    Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H; Bruecher J; Claudé R; Hoelzer D
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
    Cesana C; Carlo-Stella C; Mangoni L; Regazzi E; Garau D; Sammarelli G; Caramatti C; Almici C; Rizzoli V
    Stem Cells; 1997; 15(3):207-13. PubMed ID: 9170212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.